Cardiac Output, Blood Flow, and Blood Pressure

Cardiac Output, Blood Flow, and Blood Pressure

Cardiac Output

  • Definition: The volume of blood pumped each minute by each ventricle.

    • Formula: \text{cardiac output} = \text{stroke volume} \times \text{heart rate} \quad (\text{ml/min}) \quad (\text{ml/beat}) \quad (\text{beats/min})

  • Average Values:

    • Average heart rate = 70 beats per minute (bpm)

    • Average stroke volume = 70-80 milliliters (ml/beat)

    • Average cardiac output = 5,500 ml/minute

Cardiac Output Increases During Exercise
  • At Rest:

    • Cardiac output = 5.8 L/min.

  • During Vigorous Exercise:

    • Cardiac output = 25.6 L/min.

  • Distribution: Blood flow distribution at rest vs. vigorous exercise

    • Brain: Rest: 13%, Exercise: 3%

    • Kidneys: Rest: 4%, Exercise: 1%

    • GI Tract: Rest: 19%, Exercise: 9%

    • Skin: Rest: 2.5%, Exercise: 0.5%

    • Other Tissues: Rest: 10%, Exercise: 88% to Skeletal Muscles

Regulation of Cardiac Output

  • Heart Rate: Determined by the rate of depolarization in autorhythmic cells.

    • Increases/Decreases:

    • Increase: Due to sympathetic innervation

    • Decrease: Due to parasympathetic innervation

  • Stroke Volume: Function of:

    • Force of contraction in ventricular myocardium

    • Influenced by contractility and end-diastolic volume (EDV)

    • Influenced by:

      • Epinephrine (increases contractility)

      • Venous constriction (increases EDV)

  • Venous Return: Aided by skeletal muscle pump and respiratory pump.

Autonomic Regulation of Heart Rate
  • Increase in Heart Rate (HR) can be achieved by:

    • Decreasing parasympathetic activity

    • Increasing sympathetic input: Norepinephrine (NE) or Epinephrine (E) act on b1-receptors to speed up depolarization rate of autorhythmic cells.

  • ACh (Acetylcholine): Slows the conduction of action potentials (APs) through the AV node (increases AV node delay).

Action Potentials in Autorhythmic Cells

  • Nature of Autorhythmic Cells: Ability to generate action potentials spontaneously.

    • Membrane Potential:

    • Starts from a less negative state,

    • Threshold reached when Ca²⁺ channels open leading to depolarization.

    • Ion Movements During an Action Potential:

    • Lots of Ca²⁺ channels open, then close as K⁺ channels open leading to repolarization.

  • Pacemaker Potential:

    • Gradually becomes less negative until threshold is reached, triggering an action potential.

Modulation of Action Potentials

  • Influence of Ion Permeability:

    • Increased permeability to Na⁺ and Ca²⁺ speeds up depolarization (positive chronotropic effect).

    • Increased permeability to K⁺ causes hyperpolarization (negative chronotropic effect).

Autonomic Effects on the Heart
  • Table of Autonomic Nerve Activity:

    • Sympathetic Effects:

    • SA Node: Increased conduction rate and rate of diastolic depolarization; increased cardiac rate.

    • AV Node: Decreased conduction rate.

    • Atrial Muscle: Increased strength of contraction.

    • Ventricular Muscle: Increased strength of contraction.

    • Parasympathetic Effects:

    • SA Node: Decreased rate of diastolic depolarization; decreased cardiac rate.

    • AV Node: Decreased conduction rate.

Factors Regulating Cardiac Output

  • Stroke Volume Regulation:

    • End-Diastolic Volume (EDV) – Preload. Higher EDV results in increased contractility.

    • Total Peripheral Resistance – Afterload (End-Systolic Volume, ESV).

    • Ejection Fraction: Percentage of EDV that is ejected during ventricular contraction.

Frank-Starling Law of the Heart
  • Definition: Stroke volume is proportional to end-diastolic volume (EDV).

  • Length-Force Relationship: Muscle length (determined by volume of blood in ventricle) affects contraction strength.

  • Preload: Degree of stretch of myocardial fibers before contraction begins.

Control of Contraction Strength
  • Intrinsic Control:

    • Actin-myosin cross-bridging influences tension production.

    • Stretch of myocardium results in sensitivity of Ca²⁺ release channels.

Extrinsic Control of Contractility
  • Iotropic Effect: Increases in contraction strength via increased calcium availability to sarcomeres.

Venous Return

  • Definition: Amount of blood entering the heart from the venous circulation.

  • Factors Affecting Venous Return:

    • Blood Volume.

    • Negative intrathoracic pressure (respiratory pump).

    • Venous pressure.

Laws of Blood Flow

  • Poiseuille's Law: Describes blood flow through vessels.

    • \text{blood flow} = \frac{AP \cdot \pi r^4}{8nL} where AP = pressure, r = radius, n = viscosity, L = length of vessel.

Velocity of Blood Flow

  • Determinant for Velocity: Total cross-sectional area of vessels.

  • Slowest Flow: Occurs in capillaries and venules, allowing sufficient time for diffusion to reach equilibrium.

Blood Pressure Dynamics
  • Pressure Differences in systemic circulation:

    • Highest pressure in arteries (e.g., aorta) decreasing throughout circulatory system to lowest in vena cavae.

  • Main Factors Affecting Blood Pressure:

    • Cardiac Output (Stroke Volume, Heart Rate)

    • Total Peripheral Resistance (via vasoconstriction/dilation)

    • Blood Volume

  • Resistance: Greatest in arterioles, which are narrower than larger arteries.

Baroreceptor Reflex
  • Function: In response to increased blood pressure, baroreceptors in the walls of vessels produce more action potentials.

  • Information Integration: Relayed to the medulla oblongata to control cardiac rate and total peripheral resistance.

  • Sensitivity: Reflex is more sensitive to decreases in pressure.

Abnormal Blood Pressure Conditions

  • Hypotension:

    • BP falls too low, impairing blood flow and oxygen supply (can cause dizziness or fainting).

  • Hypertension:

    • Chronic elevation of BP may lead to vascular damage, e.g., cerebral hemorrhages or arterial rupture.

  • Treatment Measures:

    • Lifestyle modifications (e.g., smoking cessation, exercise).

    • Medications: Diuretics, Beta blockers, ACE inhibitors, ARBs (angiotensin receptor blockers).